IDENTIFICATION OF SOLUBLE APO-1 IN SUPERNATANTS OF HUMAN B-CELL AND T-CELL LINES AND INCREASED SERUM LEVELS IN B-CELL AND T-CELL LEUKEMIAS

被引:143
作者
KNIPPING, E
DEBATIN, KM
STRICKER, K
HEILIG, B
EDER, A
KRAMMER, PH
机构
[1] GERMAN CANC RES CTR, DIV IMMUNOGENET, TUMORIMMUNOL PROGRAM, D-69120 HEIDELBERG, GERMANY
[2] UNIV HEIDELBERG, CHILDRENS HOSP, HEMATOL ONCOL SECT, W-6900 HEIDELBERG, GERMANY
[3] UNIV HEIDELBERG, MED KLIN 5, HEIDELBERG, GERMANY
[4] NIH, BIOL MODIFIERS PROGRAM, BETHESDA, MD 20892 USA
[5] BENDER MEDSYST, VIENNA, AUSTRIA
关键词
D O I
10.1182/blood.V85.6.1562.bloodjournal8561562
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The cell-surface protein APO-1 is a member of the nerve growth factor (NGF)/tumor necrosis factor (TNF) receptor superfamily. APO-1 mediates apoptosis in susceptible cells upon stimulation with the monoclonal antibody anti-APO-1 or upon binding of its natural ligand. Soluble receptors had previously been identified for most members of the NGF/TNF receptor superfamily. Recently, a soluble form of APO-1 (sAPO-1) was described. We established a sandwich enzyme-linked immunosorbent assay to detect sAPO-1 in culture supernatants of human cell lines and in human sera. sAPO-1 was found in culture supernatants of different human B- and T-cell lines. Molecular weights of sAPO-1 and membrane APO-1 were similar. In addition, in comparison to healthy donors, sera from patients with different high- and low-grade malignant B- and T-cell leukemias and lymphomas contained increased levels of sAPO-1. These findings may have implications for the growth of leukemias and the diagnostic monitoring of individual patients. (C) 1995 by The American Society of Hematology.
引用
收藏
页码:1562 / 1569
页数:8
相关论文
共 65 条
[1]  
ADERKA D, 1991, CANCER RES, V51, P5602
[2]   A SOLUBLE RECEPTOR FOR INTERLEUKIN-1-BETA ENCODED BY VACCINIA VIRUS - A NOVEL MECHANISM OF VIRUS MODULATION OF THE HOST RESPONSE TO INFECTION [J].
ALCAMI, A ;
SMITH, GL .
CELL, 1992, 71 (01) :153-167
[3]   FAS TRANSDUCES ACTIVATION SIGNALS IN NORMAL HUMAN T-LYMPHOCYTES [J].
ALDERSON, MR ;
ARMITAGE, RJ ;
MARASKOVSKY, E ;
TOUGH, TW ;
ROUX, E ;
SCHOOLEY, K ;
RAMSDELL, F ;
LYNCH, DH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2231-2235
[4]  
ALTOMONTE M, 1993, CANCER RES, V53, P3343
[5]  
Black P H, 1980, Adv Cancer Res, V32, P75, DOI 10.1016/S0065-230X(08)60361-9
[6]  
CALDERHEAD DM, 1993, J IMMUNOL, V151, P5261
[7]  
CHAMULEAU MED, 1992, TRANSPLANTATION, V54, P932
[8]   PROTECTION FROM FAS-MEDIATED APOPTOSIS BY A SOLUBLE FORM OF THE FAS MOLECULE [J].
CHENG, JH ;
ZHOU, T ;
LIU, CD ;
SHAPIRO, JP ;
BRAUER, MJ ;
KIEFER, MC ;
BARR, PJ ;
MOUNTZ, JD .
SCIENCE, 1994, 263 (5154) :1759-1762
[9]  
DABATIN KM, IN PRESS LEUKEMIA
[10]   HIGH EXPRESSION OF APO-1 (CD95) ON T-LYMPHOCYTES FROM HUMAN IMMUNODEFICIENCY VIRUS-1-INFECTED CHILDREN [J].
DEBATIN, KM ;
FAHRIGFAISSNER, A ;
ENENKELSTOODT, S ;
KREUZ, W ;
BENNER, A ;
KRAMMER, P .
BLOOD, 1994, 83 (10) :3101-3103